The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro
Intracellular transport via microtubule-based dynein and kinesin family motors plays a key role in viral reproduction and transmission. We show here that Kinesin Family Member 4 (KIF4) plays an important role in HBV/HDV infection. We intended to explore host factors impacting the HBV life cycle that...
Saved in:
Published in: | PLoS pathogens Vol. 18; no. 3; p. e1009983 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Public Library of Science
01-03-2022
Public Library of Science (PLoS) |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Intracellular transport via microtubule-based dynein and kinesin family motors plays a key role in viral reproduction and transmission. We show here that Kinesin Family Member 4 (KIF4) plays an important role in HBV/HDV infection. We intended to explore host factors impacting the HBV life cycle that can be therapeutically addressed using siRNA library transfection and HBV/NLuc (HBV/NL) reporter virus infection in HepG2-hNTCP cells. KIF4 silencing resulted in a 3-fold reduction in luciferase activity following HBV/NL infection. KIF4 knockdown suppressed both HBV and HDV infection. Transient KIF4 depletion reduced surface and raised intracellular NTCP (HBV/HDV entry receptor) levels, according to both cellular fractionation and immunofluorescence analysis (IF). Overexpression of wild-type KIF4 but not ATPase-null KIF4 mutant regained the surface localization of NTCP and significantly restored HBV permissiveness in these cells. IF revealed KIF4 and NTCP colocalization across microtubule filaments, and a co-immunoprecipitation study revealed that KIF4 interacts with NTCP. KIF4 expression is regulated by FOXM1. Interestingly, we discovered that RXR agonists (Bexarotene, and Alitretinoin) down-regulated KIF4 expression via FOXM1-mediated suppression, resulting in a substantial decrease in HBV-Pre-S1 protein attachment to HepG2-hNTCP cell surface and subsequent HBV infection in both HepG2-hNTCP and primary human hepatocyte (PXB) (Bexarotene, IC50 1.89 ± 0.98 μM) cultures. Overall, our findings show that human KIF4 is a critical regulator of NTCP surface transport and localization, which is required for NTCP to function as a receptor for HBV/HDV entry. Furthermore, small molecules that suppress or alleviate KIF4 expression would be potential antiviral candidates targeting HBV and HDV entry. |
---|---|
AbstractList | Intracellular transport via microtubule-based dynein and kinesin family motors plays a key role in viral reproduction and transmission. We show here that Kinesin Family Member 4 (KIF4) plays an important role in HBV/HDV infection. We intended to explore host factors impacting the HBV life cycle that can be therapeutically addressed using siRNA library transfection and HBV/NLuc (HBV/NL) reporter virus infection in HepG2-hNTCP cells. KIF4 silencing resulted in a 3-fold reduction in luciferase activity following HBV/NL infection. KIF4 knockdown suppressed both HBV and HDV infection. Transient KIF4 depletion reduced surface and raised intracellular NTCP (HBV/HDV entry receptor) levels, according to both cellular fractionation and immunofluorescence analysis (IF). Overexpression of wild-type KIF4 but not ATPase-null KIF4 mutant regained the surface localization of NTCP and significantly restored HBV permissiveness in these cells. IF revealed KIF4 and NTCP colocalization across microtubule filaments, and a co-immunoprecipitation study revealed that KIF4 interacts with NTCP. KIF4 expression is regulated by FOXM1. Interestingly, we discovered that RXR agonists (Bexarotene, and Alitretinoin) down-regulated KIF4 expression via FOXM1-mediated suppression, resulting in a substantial decrease in HBV-Pre-S1 protein attachment to HepG2-hNTCP cell surface and subsequent HBV infection in both HepG2-hNTCP and primary human hepatocyte (PXB) (Bexarotene, IC50 1.89 ± 0.98 μM) cultures. Overall, our findings show that human KIF4 is a critical regulator of NTCP surface transport and localization, which is required for NTCP to function as a receptor for HBV/HDV entry. Furthermore, small molecules that suppress or alleviate KIF4 expression would be potential antiviral candidates targeting HBV and HDV entry. Intracellular transport via microtubule-based dynein and kinesin family motors plays a key role in viral reproduction and transmission. We show here that Kinesin Family Member 4 (KIF4) plays an important role in HBV/HDV infection. We intended to explore host factors impacting the HBV life cycle that can be therapeutically addressed using siRNA library transfection and HBV/NLuc (HBV/NL) reporter virus infection in HepG2-hNTCP cells. KIF4 silencing resulted in a 3-fold reduction in luciferase activity following HBV/NL infection. KIF4 knockdown suppressed both HBV and HDV infection. Transient KIF4 depletion reduced surface and raised intracellular NTCP (HBV/HDV entry receptor) levels, according to both cellular fractionation and immunofluorescence analysis (IF). Overexpression of wild-type KIF4 but not ATPase-null KIF4 mutant regained the surface localization of NTCP and significantly restored HBV permissiveness in these cells. IF revealed KIF4 and NTCP colocalization across microtubule filaments, and a co-immunoprecipitation study revealed that KIF4 interacts with NTCP. KIF4 expression is regulated by FOXM1. Interestingly, we discovered that RXR agonists (Bexarotene, and Alitretinoin) down-regulated KIF4 expression via FOXM1-mediated suppression, resulting in a substantial decrease in HBV-Pre-S1 protein attachment to HepG2-hNTCP cell surface and subsequent HBV infection in both HepG2-hNTCP and primary human hepatocyte (PXB) (Bexarotene, IC 50 1.89 ± 0.98 μM) cultures. Overall, our findings show that human KIF4 is a critical regulator of NTCP surface transport and localization, which is required for NTCP to function as a receptor for HBV/HDV entry. Furthermore, small molecules that suppress or alleviate KIF4 expression would be potential antiviral candidates targeting HBV and HDV entry. Understanding HBV/HDV entry machinery and the mechanism by which NTCP (HBV/HDV entry receptor) surface expression is regulated is crucial to develop antiviral entry inhibitors. We found that NTCP surface transport is mainly controlled by the motor kinesin KIF4. Surprisingly, KIF4 was negatively regulated by RXR receptors through FOXM1-mediated suppression. This study not only mechanistically correlated the role of RXR receptors in regulating HBV/HDV entry but also suggested a novel approach to develop therapeutic rexinoids for preventing HBV and/or HDV infections in important clinical situations, such as in patients undergoing liver transplantation or those who are at a high risk of HBV infection and unresponsive to HBV vaccination. Intracellular transport via microtubule-based dynein and kinesin family motors plays a key role in viral reproduction and transmission. We show here that Kinesin Family Member 4 (KIF4) plays an important role in HBV/HDV infection. We intended to explore host factors impacting the HBV life cycle that can be therapeutically addressed using siRNA library transfection and HBV/NLuc (HBV/NL) reporter virus infection in HepG2-hNTCP cells. KIF4 silencing resulted in a 3-fold reduction in luciferase activity following HBV/NL infection. KIF4 knockdown suppressed both HBV and HDV infection. Transient KIF4 depletion reduced surface and raised intracellular NTCP (HBV/HDV entry receptor) levels, according to both cellular fractionation and immunofluorescence analysis (IF). Overexpression of wild-type KIF4 but not ATPase-null KIF4 mutant regained the surface localization of NTCP and significantly restored HBV permissiveness in these cells. IF revealed KIF4 and NTCP colocalization across microtubule filaments, and a co-immunoprecipitation study revealed that KIF4 interacts with NTCP. KIF4 expression is regulated by FOXM1. Interestingly, we discovered that RXR agonists (Bexarotene, and Alitretinoin) down-regulated KIF4 expression via FOXM1-mediated suppression, resulting in a substantial decrease in HBV-Pre-S1 protein attachment to HepG2-hNTCP cell surface and subsequent HBV infection in both HepG2-hNTCP and primary human hepatocyte (PXB) (Bexarotene, IC.sub.50 1.89 ± 0.98 [mu]M) cultures. Overall, our findings show that human KIF4 is a critical regulator of NTCP surface transport and localization, which is required for NTCP to function as a receptor for HBV/HDV entry. Furthermore, small molecules that suppress or alleviate KIF4 expression would be potential antiviral candidates targeting HBV and HDV entry. Intracellular transport via microtubule-based dynein and kinesin family motors plays a key role in viral reproduction and transmission. We show here that Kinesin Family Member 4 (KIF4) plays an important role in HBV/HDV infection. We intended to explore host factors impacting the HBV life cycle that can be therapeutically addressed using siRNA library transfection and HBV/NLuc (HBV/NL) reporter virus infection in HepG2-hNTCP cells. KIF4 silencing resulted in a 3-fold reduction in luciferase activity following HBV/NL infection. KIF4 knockdown suppressed both HBV and HDV infection. Transient KIF4 depletion reduced surface and raised intracellular NTCP (HBV/HDV entry receptor) levels, according to both cellular fractionation and immunofluorescence analysis (IF). Overexpression of wild-type KIF4 but not ATPase-null KIF4 mutant regained the surface localization of NTCP and significantly restored HBV permissiveness in these cells. IF revealed KIF4 and NTCP colocalization across microtubule filaments, and a co-immunoprecipitation study revealed that KIF4 interacts with NTCP. KIF4 expression is regulated by FOXM1. Interestingly, we discovered that RXR agonists (Bexarotene, and Alitretinoin) down-regulated KIF4 expression via FOXM1-mediated suppression, resulting in a substantial decrease in HBV-Pre-S1 protein attachment to HepG2-hNTCP cell surface and subsequent HBV infection in both HepG2-hNTCP and primary human hepatocyte (PXB) (Bexarotene, IC 50 1.89 ± 0.98 μM) cultures. Overall, our findings show that human KIF4 is a critical regulator of NTCP surface transport and localization, which is required for NTCP to function as a receptor for HBV/HDV entry. Furthermore, small molecules that suppress or alleviate KIF4 expression would be potential antiviral candidates targeting HBV and HDV entry. |
Audience | Academic |
Author | Shimotohno, Kunitada Fukano, Kento Shoji, Ikuo Gad, Sameh A Sureau, Camille Tsuge, Masataka Kato, Takanobu Wakita, Takaji Murayama, Asako Li, Yingfang Watanabe, Noriyuki Sugiyama, Masaya Muramatsu, Masamichi Oshima, Mizuki Chayama, Kazuaki Nozaki, Tomoyoshi Wakae, Kosho Aly, Hussein H |
AuthorAffiliation | 6 Graduate School of Science and Technology, Tokyo University of Science, Noda, Japan 12 RIKEN Center for Integrative Medical Sciences, Yokohama, Japan 7 Institut National de la Transfusion Sanguine, Paris, France 2 Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan 9 Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan 10 Collaborative Research Laboratory of Medical Innovation, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan 3 Department of Microbiology and Immunology, Faculty of Pharmacy, Minia University, Minia, Egypt 5 Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima, Japan 1 Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan 11 Research Center for Hepatology and Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan 8 Center for |
AuthorAffiliation_xml | – name: 5 Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima, Japan – name: 8 Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan – name: 7 Institut National de la Transfusion Sanguine, Paris, France – name: 11 Research Center for Hepatology and Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan – name: 4 Genome Medical Sciences Project, National Center for Global Health and Medicine, Chiba, Japan – name: 6 Graduate School of Science and Technology, Tokyo University of Science, Noda, Japan – name: 9 Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan – name: The Pennsylvania State University College of Medicine, UNITED STATES – name: 2 Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan – name: 3 Department of Microbiology and Immunology, Faculty of Pharmacy, Minia University, Minia, Egypt – name: 1 Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan – name: 12 RIKEN Center for Integrative Medical Sciences, Yokohama, Japan – name: 10 Collaborative Research Laboratory of Medical Innovation, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan |
Author_xml | – sequence: 1 givenname: Sameh A orcidid: 0000-0003-3612-2977 surname: Gad fullname: Gad, Sameh A organization: Department of Microbiology and Immunology, Faculty of Pharmacy, Minia University, Minia, Egypt – sequence: 2 givenname: Masaya orcidid: 0000-0002-9084-7197 surname: Sugiyama fullname: Sugiyama, Masaya organization: Genome Medical Sciences Project, National Center for Global Health and Medicine, Chiba, Japan – sequence: 3 givenname: Masataka orcidid: 0000-0001-7591-8287 surname: Tsuge fullname: Tsuge, Masataka organization: Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima, Japan – sequence: 4 givenname: Kosho surname: Wakae fullname: Wakae, Kosho organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 5 givenname: Kento orcidid: 0000-0002-0030-6072 surname: Fukano fullname: Fukano, Kento organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 6 givenname: Mizuki surname: Oshima fullname: Oshima, Mizuki organization: Graduate School of Science and Technology, Tokyo University of Science, Noda, Japan – sequence: 7 givenname: Camille surname: Sureau fullname: Sureau, Camille organization: Institut National de la Transfusion Sanguine, Paris, France – sequence: 8 givenname: Noriyuki orcidid: 0000-0001-6101-6928 surname: Watanabe fullname: Watanabe, Noriyuki organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 9 givenname: Takanobu orcidid: 0000-0003-1620-1360 surname: Kato fullname: Kato, Takanobu organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 10 givenname: Asako surname: Murayama fullname: Murayama, Asako organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 11 givenname: Yingfang surname: Li fullname: Li, Yingfang organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 12 givenname: Ikuo orcidid: 0000-0002-0730-4379 surname: Shoji fullname: Shoji, Ikuo organization: Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Japan – sequence: 13 givenname: Kunitada surname: Shimotohno fullname: Shimotohno, Kunitada organization: Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba, Japan – sequence: 14 givenname: Kazuaki surname: Chayama fullname: Chayama, Kazuaki organization: RIKEN Center for Integrative Medical Sciences, Yokohama, Japan – sequence: 15 givenname: Masamichi orcidid: 0000-0002-0153-3533 surname: Muramatsu fullname: Muramatsu, Masamichi organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 16 givenname: Takaji surname: Wakita fullname: Wakita, Takaji organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 17 givenname: Tomoyoshi orcidid: 0000-0003-1354-5133 surname: Nozaki fullname: Nozaki, Tomoyoshi organization: Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan – sequence: 18 givenname: Hussein H orcidid: 0000-0002-2455-0694 surname: Aly fullname: Aly, Hussein H organization: Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35312737$$D View this record in MEDLINE/PubMed |
BookMark | eNqVk01v1DAQhiNURD_gHyCwxAUOu7Xjj2wuSKVQuqIqaFkqbpbjTLJus_ZiOxXlF_Czcdht1UW9oBwceZ55Z-aVZz_bsc5Clj0neExoQQ4vXe-t6sarlYpjgnFZTuijbI9wTkcFLdjOvf_dbD-ES4wZoUQ8yXYppyRPgb3s93wB6MpYCMaiT9MThpZQGxUhoNN3F4en7y8Q2OhvUFx417eLdALy0PadisZZ5BoUet8oDeh8fvwFdU6rzvxaB5WtkVYWVYCi8i1EqFF1g2bfZ0i1zpoQA0plr0307mn2uFFdgGeb8yD7dvJhfnw6Ovv8cXp8dDbSQpA4yidVmcavMC9zTnheMFFPKAVSCAENF4SWoHiB67zGmkFRFDUp8qoh5YRpJQQ9yF6udVedC3JjYpC54IRwTFmeiOmaqJ26lCtvlsrfSKeM_HvhfCuVj0Z3IIGIhuZ10WjGWc7LUvFKEIGx0JyICpLW2021vkrG6sFL1W2JbkesWcjWXctJWWCeD-2-3gh496OHEOXSBA1dpyy4fuibkQkXRT70_eof9OHpNlSr0gDGNi7V1YOoPBJlyWiJGU3U-AEqfTUsjU4PsTHpfivhzVZCYiL8jK3qQ5DTr7P_YM-3WbZmtXcheGjuvCNYDntwO6Qc9kBu9iClvbjv-13S7cOnfwCPTAMJ |
CitedBy_id | crossref_primary_10_1080_17460794_2024_2342135 crossref_primary_10_1016_j_jpha_2024_100979 crossref_primary_10_1083_jcb_202212084 crossref_primary_10_2217_fvl_2023_0210 crossref_primary_10_1016_j_bcp_2023_115956 crossref_primary_10_1515_hsz_2022_0345 |
Cites_doi | 10.1073/pnas.1811064116 10.1136/gutjnl-2015-309809 10.1136/gut.24.7.618 10.1073/pnas.111145398 10.1056/NEJM199312163292503 10.1111/cas.12799 10.1101/gad.282855.116 10.1073/pnas.2021475118 10.1128/JVI.02203-18 10.1128/JVI.01771-17 10.1038/s41598-017-11015-4 10.1136/bmj.m2200 10.1016/j.jhep.2012.12.008 10.1016/j.antiviral.2012.12.008 10.1016/j.jhep.2016.11.009 10.1111/liv.13427 10.1016/j.jhep.2016.02.013 10.1016/j.antiviral.2014.03.017 10.1128/JVI.73.12.10508-10513.1999 10.1242/jcs.02304 10.1074/jbc.M116.724641 10.1016/j.bbrc.2013.12.052 10.1002/hep.26982 10.1002/hep.510250521 10.1042/BCJ20170548 10.1128/JVI.01855-15 10.1016/j.mcn.2014.09.003 10.1016/j.bbrc.2008.05.065 10.1016/j.coviro.2018.04.004 10.1128/JVI.00767-21 10.1038/nrm2774 10.1083/jcb.129.3.709 10.1016/j.ejphar.2020.173346 10.3851/IMP2965 10.1074/jbc.M113.501122 10.1016/0092-8674(95)90376-3 10.1371/journal.pone.0215234 10.3389/fmicb.2018.03257 10.1016/j.antiviral.2015.06.007 10.1371/journal.ppat.1007055 10.1083/jcb.149.1.141 10.1242/jcs.064113 10.1016/j.chom.2013.10.012 10.1002/hep.27694 10.1038/ncb1217 10.1073/pnas.78.6.3906 10.1016/j.antiviral.2014.09.009 10.1016/j.gene.2018.08.005 10.1186/s13046-019-1202-3 10.1128/jvi.68.6.4063-4066.1994 10.3892/mmr.2015.3792 10.1128/jvi.63.5.1945-1950.1989 10.7150/jca.26052 10.1136/gutjnl-2016-312162 10.3389/fimmu.2021.712241 10.1002/hep.27240 10.1128/JVI.02478-06 10.3389/fcimb.2020.00074 10.1074/jbc.M114.602540 10.1083/jcb.200403036 10.1152/ajpgi.2001.280.6.G1305 10.1002/hep.24707 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2022 Public Library of Science 2022 Gad et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 Gad et al 2022 Gad et al |
Copyright_xml | – notice: COPYRIGHT 2022 Public Library of Science – notice: 2022 Gad et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 Gad et al 2022 Gad et al |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION ISN ISR 3V. 7QL 7U9 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1371/journal.ppat.1009983 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Gale In Context: Canada Gale In Context: Science ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | KIF4 regulates NTCP-mediated HBV/HDV entry |
EISSN | 1553-7374 |
Editor | Hu, Jianming |
Editor_xml | – sequence: 1 givenname: Jianming surname: Hu fullname: Hu, Jianming |
EndPage | e1009983 |
ExternalDocumentID | 2651150342 oai_doaj_org_article_e16f32d7fc4542599a5b616006c516be A699439043 10_1371_journal_ppat_1009983 35312737 |
Genre | Journal Article |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GrantInformation_xml | – fundername: ; grantid: 19K07586 – fundername: ; grantid: 20fk0310109h0004 – fundername: ; grantid: 21fk0310109j0405 – fundername: ; grantid: 21fk0310103j0305 – fundername: ; grantid: Egyptian Japanese Education Partnership-3 (EJEP-3) PhD scholarship – fundername: ; grantid: 21fk0310104j0905 |
GroupedDBID | --- 123 29O 2WC 3V. 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ AAFWJ ABDBF ABUWG ACGFO ACIHN ACPRK ADBBV ADRAZ AEAQA AENEX AFKRA AFPKN AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS B0M BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI BWKFM CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EAP EAS EBD ECM EIF EMK EMOBN ESX F5P FPL FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IHR INH INR IPNFZ ISN ISR ITC KQ8 LK8 M1P M48 M7P MM. M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO PV9 QF4 QN7 RIG RNS RPM RZL SV3 TR2 TUS UKHRP WOQ WOW ~8M AAYXX CITATION 7QL 7U9 7XB 8FK AZQEC C1K DWQXO GNUQQ H94 K9. PQEST PQUKI PRINS 7X8 5PM - AAPBV ABPTK ADACO BBAFP |
ID | FETCH-LOGICAL-c661t-28b9137b05925152746d833e1766ef56139ea570d2d0c4e777d172bf1984ca663 |
IEDL.DBID | RPM |
ISSN | 1553-7374 1553-7366 |
IngestDate | Sun May 01 00:10:38 EDT 2022 Tue Oct 22 15:13:37 EDT 2024 Tue Sep 17 21:34:57 EDT 2024 Fri Aug 16 23:38:09 EDT 2024 Thu Oct 10 18:33:20 EDT 2024 Tue Nov 19 20:46:05 EST 2024 Tue Nov 12 22:08:31 EST 2024 Thu Aug 01 19:39:10 EDT 2024 Thu Aug 01 20:12:23 EDT 2024 Fri Aug 23 01:31:07 EDT 2024 Sat Sep 28 08:21:21 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c661t-28b9137b05925152746d833e1766ef56139ea570d2d0c4e777d172bf1984ca663 |
Notes | new_version ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 The authors have declared that no competing interests exist. |
ORCID | 0000-0002-0730-4379 0000-0003-1620-1360 0000-0002-0153-3533 0000-0003-1354-5133 0000-0001-6101-6928 0000-0002-2455-0694 0000-0002-9084-7197 0000-0003-3612-2977 0000-0001-7591-8287 0000-0002-0030-6072 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970526/ |
PMID | 35312737 |
PQID | 2651150342 |
PQPubID | 1436335 |
ParticipantIDs | plos_journals_2651150342 doaj_primary_oai_doaj_org_article_e16f32d7fc4542599a5b616006c516be pubmedcentral_primary_oai_pubmedcentral_nih_gov_8970526 proquest_miscellaneous_2641856722 proquest_journals_2651150342 gale_infotracmisc_A699439043 gale_infotracacademiconefile_A699439043 gale_incontextgauss_ISR_A699439043 gale_incontextgauss_ISN_A699439043 crossref_primary_10_1371_journal_ppat_1009983 pubmed_primary_35312737 |
PublicationCentury | 2000 |
PublicationDate | 2022-03-01 |
PublicationDateYYYYMMDD | 2022-03-01 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
PublicationTitle | PLoS pathogens |
PublicationTitleAlternate | PLoS Pathog |
PublicationYear | 2022 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | M. Nassal (ppat.1009983.ref001) 2015; 64 CL Zhu (ppat.1009983.ref015) 2015; 12 M Blanchet (ppat.1009983.ref037) 2014; 106 HN Skold (ppat.1009983.ref006) 2005; 118 S Shimura (ppat.1009983.ref065) 2017; 66 C Sureau (ppat.1009983.ref002) 2016; 64 NM Gretskaya (ppat.1009983.ref043) 2020; 883 T Tu (ppat.1009983.ref045) 2018; 30 K Osei-Sarfo (ppat.1009983.ref021) 2019; 14 S Gudima (ppat.1009983.ref059) 2007; 81 W Zhou (ppat.1009983.ref017) 2017; 37 D Samuel (ppat.1009983.ref047) 1993; 329 L Deng (ppat.1009983.ref060) 2019; 93 J Lucifora (ppat.1009983.ref039) 2013; 97 S Tsukuda (ppat.1009983.ref041) 2015; 290 AQ Sun (ppat.1009983.ref033) 2001; 280 J Laoukili (ppat.1009983.ref056) 2005; 7 H Yan (ppat.1009983.ref003) 2012; 3 FM Vaz (ppat.1009983.ref034) 2015; 61 HC Huang (ppat.1009983.ref042) 2014; 111 T Volz (ppat.1009983.ref022) 2013; 58 MK Ibrahim (ppat.1009983.ref053) 2021 H Nishitsuji (ppat.1009983.ref023) 2015; 106 J Scotto (ppat.1009983.ref050) 1983; 24 MK Ibrahim (ppat.1009983.ref016) 2021; 95 J Powers (ppat.1009983.ref008) 2004; 166 Y Sabo (ppat.1009983.ref012) 2013; 14 M Kaneko (ppat.1009983.ref036) 2015; 89 BC Williams (ppat.1009983.ref009) 1995; 129 K Watashi (ppat.1009983.ref046) 2014; 59 L Sheng (ppat.1009983.ref011) 2018; 678 CM Gaunt (ppat.1009983.ref029) 2021; 12 JD Londino (ppat.1009983.ref062) 2017; 474 Y Shi (ppat.1009983.ref004) 2020; 370 N Janakiram (ppat.1009983.ref044) 2007; 67 D Peretti (ppat.1009983.ref020) 2000; 149 K Watashi (ppat.1009983.ref064) 2013; 288 BL Shneider (ppat.1009983.ref031) 1997; 25 HH Aly (ppat.1009983.ref061) 2016; 291 D Slijepcevic (ppat.1009983.ref035) 2015; 62 M Iwamoto (ppat.1009983.ref051) 2014; 443 I Vernos (ppat.1009983.ref010) 1995; 81 G Hu (ppat.1009983.ref014) 2019; 38 M Takahashi (ppat.1009983.ref054) 2016; 30 TG Heintz (ppat.1009983.ref025) 2014; 63 N Hirokawa (ppat.1009983.ref024) 2009; 10 M Song (ppat.1009983.ref028) 2018; 92 M Iwamoto (ppat.1009983.ref052) 2017; 7 G Wu (ppat.1009983.ref018) 2008; 372 A Schulze (ppat.1009983.ref032) 2012; 55 XJ Wang (ppat.1009983.ref040) 2015; 120 Q Hu (ppat.1009983.ref030) 2020; 10 L Yang (ppat.1009983.ref048) 2018; 9 S Mukhopadhyay (ppat.1009983.ref063) 2021; 118 SA Endow (ppat.1009983.ref007) 2010; 123 J Zhou (ppat.1009983.ref013) 2018; 14 K Fukano (ppat.1009983.ref055) 2018; 9 C Sureau (ppat.1009983.ref058) 1994; 68 H Miki (ppat.1009983.ref005) 2001; 98 MY Kuo (ppat.1009983.ref057) 1989; 63 C Ko (ppat.1009983.ref038) 2015; 20 C Brechot (ppat.1009983.ref049) 1981; 78 L Allweiss (ppat.1009983.ref019) 2018; 67 M Iwamoto (ppat.1009983.ref027) 2019; 116 Y Tang (ppat.1009983.ref026) 1999; 73 |
References_xml | – volume: 116 start-page: 8487 issue: 17 year: 2019 ident: ppat.1009983.ref027 article-title: Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1811064116 contributor: fullname: M Iwamoto – volume: 64 start-page: 1972 issue: 12 year: 2015 ident: ppat.1009983.ref001 article-title: HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B publication-title: Gut doi: 10.1136/gutjnl-2015-309809 contributor: fullname: M. Nassal – volume: 3 year: 2012 ident: ppat.1009983.ref003 article-title: Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus publication-title: Elife contributor: fullname: H Yan – volume: 24 start-page: 618 issue: 7 year: 1983 ident: ppat.1009983.ref050 article-title: Hepatitis B virus DNA in children’s liver diseases: detection by blot hybridisation in liver and serum publication-title: Gut doi: 10.1136/gut.24.7.618 contributor: fullname: J Scotto – volume: 98 start-page: 7004 issue: 13 year: 2001 ident: ppat.1009983.ref005 article-title: All kinesin superfamily protein, KIF, genes in mouse and human publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.111145398 contributor: fullname: H Miki – volume: 329 start-page: 1842 issue: 25 year: 1993 ident: ppat.1009983.ref047 article-title: Liver transplantation in European patients with the hepatitis B surface antigen publication-title: N Engl J Med doi: 10.1056/NEJM199312163292503 contributor: fullname: D Samuel – volume: 106 start-page: 1616 issue: 11 year: 2015 ident: ppat.1009983.ref023 article-title: Novel reporter system to monitor early stages of the hepatitis B virus life cycle publication-title: Cancer Sci doi: 10.1111/cas.12799 contributor: fullname: H Nishitsuji – volume: 30 start-page: 1931 issue: 17 year: 2016 ident: ppat.1009983.ref054 article-title: Condensin I-mediated mitotic chromosome assembly requires association with chromokinesin KIF4A publication-title: Genes Dev doi: 10.1101/gad.282855.116 contributor: fullname: M Takahashi – volume: 118 issue: 6 year: 2021 ident: ppat.1009983.ref063 article-title: Autophagy is required for proper cysteine homeostasis in pancreatic cancer through regulation of SLC7A11 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.2021475118 contributor: fullname: S Mukhopadhyay – volume: 93 issue: 6 year: 2019 ident: ppat.1009983.ref060 article-title: Peroxiredoxin 1, a Novel HBx-Interacting Protein, Interacts with Exosome Component 5 and Negatively Regulates Hepatitis B Virus (HBV) Propagation through Degradation of HBV RNA. publication-title: J Virol doi: 10.1128/JVI.02203-18 contributor: fullname: L Deng – volume: 92 issue: 8 year: 2018 ident: ppat.1009983.ref028 article-title: Silencing Retinoid X Receptor Alpha Expression Enhances Early-Stage Hepatitis B Virus Infection In Cell Cultures publication-title: J Virol doi: 10.1128/JVI.01771-17 contributor: fullname: M Song – volume: 7 start-page: 10620 issue: 1 year: 2017 ident: ppat.1009983.ref052 article-title: Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication. publication-title: Sci Rep doi: 10.1038/s41598-017-11015-4 contributor: fullname: M Iwamoto – volume: 370 start-page: m2200 year: 2020 ident: ppat.1009983.ref004 article-title: Hepatitis B virus persistence and reactivation publication-title: BMJ doi: 10.1136/bmj.m2200 contributor: fullname: Y Shi – volume: 58 start-page: 861 issue: 5 year: 2013 ident: ppat.1009983.ref022 article-title: The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus publication-title: J Hepatol doi: 10.1016/j.jhep.2012.12.008 contributor: fullname: T Volz – volume: 97 start-page: 195 issue: 2 year: 2013 ident: ppat.1009983.ref039 article-title: Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes publication-title: Antiviral Res doi: 10.1016/j.antiviral.2012.12.008 contributor: fullname: J Lucifora – volume: 66 start-page: 685 issue: 4 year: 2017 ident: ppat.1009983.ref065 article-title: Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity publication-title: J Hepatol doi: 10.1016/j.jhep.2016.11.009 contributor: fullname: S Shimura – volume: 67 start-page: 1657 issue: 9 Supplement year: 2007 ident: ppat.1009983.ref044 article-title: Combined effects of raloxifene (SERM) and bexarotene (Rexinoid) on growth suppression of colon cancer cells. publication-title: Cancer Research contributor: fullname: N Janakiram – volume: 37 start-page: 1632 issue: 11 year: 2017 ident: ppat.1009983.ref017 article-title: Predictive model for inflammation grades of chronic hepatitis B: Large-scale analysis of clinical parameters and gene expressions publication-title: Liver Int doi: 10.1111/liv.13427 contributor: fullname: W Zhou – volume: 64 start-page: S102 issue: 1 Suppl year: 2016 ident: ppat.1009983.ref002 article-title: The hepatitis delta virus: Replication and pathogenesis publication-title: J Hepatol doi: 10.1016/j.jhep.2016.02.013 contributor: fullname: C Sureau – volume: 106 start-page: 111 year: 2014 ident: ppat.1009983.ref037 article-title: Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle publication-title: Antiviral Res doi: 10.1016/j.antiviral.2014.03.017 contributor: fullname: M Blanchet – volume: 73 start-page: 10508 issue: 12 year: 1999 ident: ppat.1009983.ref026 article-title: Cellular motor protein KIF-4 associates with retroviral Gag publication-title: J Virol doi: 10.1128/JVI.73.12.10508-10513.1999 contributor: fullname: Y Tang – volume: 118 start-page: 1745 issue: Pt 8 year: 2005 ident: ppat.1009983.ref006 article-title: Assembly pathway of the anastral Drosophila oocyte meiosis I spindle publication-title: J Cell Sci doi: 10.1242/jcs.02304 contributor: fullname: HN Skold – volume: 291 start-page: 15958 issue: 31 year: 2016 ident: ppat.1009983.ref061 article-title: RNA Exosome Complex Regulates Stability of the Hepatitis B Virus X-mRNA Transcript in a Non-stop-mediated (NSD) RNA Quality Control Mechanism. publication-title: J Biol Chem doi: 10.1074/jbc.M116.724641 contributor: fullname: HH Aly – volume: 443 start-page: 808 issue: 3 year: 2014 ident: ppat.1009983.ref051 article-title: Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2013.12.052 contributor: fullname: M Iwamoto – volume: 59 start-page: 1726 issue: 5 year: 2014 ident: ppat.1009983.ref046 article-title: Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP). publication-title: Hepatology doi: 10.1002/hep.26982 contributor: fullname: K Watashi – volume: 25 start-page: 1176 issue: 5 year: 1997 ident: ppat.1009983.ref031 article-title: Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia publication-title: Hepatology doi: 10.1002/hep.510250521 contributor: fullname: BL Shneider – volume: 474 start-page: 3543 issue: 20 year: 2017 ident: ppat.1009983.ref062 article-title: Post-translational modification of the interferon-gamma receptor alters its stability and signaling publication-title: Biochem J doi: 10.1042/BCJ20170548 contributor: fullname: JD Londino – volume: 89 start-page: 11945 issue: 23 year: 2015 ident: ppat.1009983.ref036 article-title: A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide publication-title: J Virol doi: 10.1128/JVI.01855-15 contributor: fullname: M Kaneko – year: 2021 ident: ppat.1009983.ref053 article-title: MafF is an antiviral host factor that suppresses transcription from Hepatitis B Virus core promoter publication-title: J Virol contributor: fullname: MK Ibrahim – volume: 63 start-page: 60 year: 2014 ident: ppat.1009983.ref025 article-title: Kinesin KIF4A transports integrin beta1 in developing axons of cortical neurons publication-title: Mol Cell Neurosci doi: 10.1016/j.mcn.2014.09.003 contributor: fullname: TG Heintz – volume: 372 start-page: 454 issue: 3 year: 2008 ident: ppat.1009983.ref018 article-title: Structural requirements of chromokinesin Kif4A for its proper function in mitosis publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2008.05.065 contributor: fullname: G Wu – volume: 30 start-page: 68 year: 2018 ident: ppat.1009983.ref045 article-title: Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections. publication-title: Curr Opin Virol doi: 10.1016/j.coviro.2018.04.004 contributor: fullname: T Tu – volume: 95 start-page: e0076721 issue: 15 year: 2021 ident: ppat.1009983.ref016 article-title: MafF Is an Antiviral Host Factor That Suppresses Transcription from Hepatitis B Virus Core Promoter publication-title: J Virol doi: 10.1128/JVI.00767-21 contributor: fullname: MK Ibrahim – volume: 10 start-page: 682 issue: 10 year: 2009 ident: ppat.1009983.ref024 article-title: Kinesin superfamily motor proteins and intracellular transport publication-title: Nature Reviews Molecular Cell Biology doi: 10.1038/nrm2774 contributor: fullname: N Hirokawa – volume: 129 start-page: 709 issue: 3 year: 1995 ident: ppat.1009983.ref009 article-title: The Drosophila kinesin-like protein KLP3A is a midbody component required for central spindle assembly and initiation of cytokinesis publication-title: J Cell Biol doi: 10.1083/jcb.129.3.709 contributor: fullname: BC Williams – volume: 883 start-page: 173346 year: 2020 ident: ppat.1009983.ref043 article-title: Novel bexarotene derivatives: Synthesis and cytotoxicity evaluation for glioma cells in 2D and 3D in vitro models publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2020.173346 contributor: fullname: NM Gretskaya – volume: 20 start-page: 835 issue: 8 year: 2015 ident: ppat.1009983.ref038 article-title: The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide. publication-title: Antivir Ther. doi: 10.3851/IMP2965 contributor: fullname: C Ko – volume: 288 start-page: 31715 issue: 44 year: 2013 ident: ppat.1009983.ref064 article-title: Interleukin-1 and tumor necrosis factor-alpha trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID). publication-title: J Biol Chem doi: 10.1074/jbc.M113.501122 contributor: fullname: K Watashi – volume: 81 start-page: 117 issue: 1 year: 1995 ident: ppat.1009983.ref010 article-title: Xklp1, a chromosomal Xenopus kinesin-like protein essential for spindle organization and chromosome positioning publication-title: Cell doi: 10.1016/0092-8674(95)90376-3 contributor: fullname: I Vernos – volume: 14 start-page: e0215234 issue: 4 year: 2019 ident: ppat.1009983.ref021 article-title: Retinoids induce antagonism between FOXO3A and FOXM1 transcription factors in human oral squamous cell carcinoma (OSCC) cells. publication-title: PLoS One. doi: 10.1371/journal.pone.0215234 contributor: fullname: K Osei-Sarfo – volume: 9 start-page: 3257 year: 2018 ident: ppat.1009983.ref055 article-title: Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes. publication-title: Front Microbiol. doi: 10.3389/fmicb.2018.03257 contributor: fullname: K Fukano – volume: 120 start-page: 140 year: 2015 ident: ppat.1009983.ref040 article-title: Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide activity. publication-title: Antiviral Res doi: 10.1016/j.antiviral.2015.06.007 contributor: fullname: XJ Wang – volume: 14 start-page: e1007055 issue: 5 year: 2018 ident: ppat.1009983.ref013 article-title: Role of kinesins in directed adenovirus transport and cytoplasmic exploration. publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1007055 contributor: fullname: J Zhou – volume: 149 start-page: 141 issue: 1 year: 2000 ident: ppat.1009983.ref020 article-title: Evidence for the involvement of KIF4 in the anterograde transport of L1-containing vesicles publication-title: J Cell Biol doi: 10.1083/jcb.149.1.141 contributor: fullname: D Peretti – volume: 123 start-page: 3420 issue: Pt 20 year: 2010 ident: ppat.1009983.ref007 article-title: Kinesins at a glance publication-title: J Cell Sci doi: 10.1242/jcs.064113 contributor: fullname: SA Endow – volume: 14 start-page: 535 issue: 5 year: 2013 ident: ppat.1009983.ref012 article-title: HIV-1 induces the formation of stable microtubules to enhance early infection publication-title: Cell Host Microbe doi: 10.1016/j.chom.2013.10.012 contributor: fullname: Y Sabo – volume: 62 start-page: 207 issue: 1 year: 2015 ident: ppat.1009983.ref035 article-title: Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice. publication-title: Hepatology doi: 10.1002/hep.27694 contributor: fullname: D Slijepcevic – volume: 7 start-page: 126 issue: 2 year: 2005 ident: ppat.1009983.ref056 article-title: FoxM1 is required for execution of the mitotic programme and chromosome stability publication-title: Nat Cell Biol doi: 10.1038/ncb1217 contributor: fullname: J Laoukili – volume: 78 start-page: 3906 issue: 6 year: 1981 ident: ppat.1009983.ref049 article-title: State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.78.6.3906 contributor: fullname: C Brechot – volume: 111 start-page: 100 year: 2014 ident: ppat.1009983.ref042 article-title: (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes. publication-title: Antiviral Res doi: 10.1016/j.antiviral.2014.09.009 contributor: fullname: HC Huang – volume: 678 start-page: 90 year: 2018 ident: ppat.1009983.ref011 article-title: The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential publication-title: Gene doi: 10.1016/j.gene.2018.08.005 contributor: fullname: L Sheng – volume: 38 start-page: 188 issue: 1 year: 2019 ident: ppat.1009983.ref014 article-title: FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-019-1202-3 contributor: fullname: G Hu – volume: 68 start-page: 4063 issue: 6 year: 1994 ident: ppat.1009983.ref058 article-title: The middle hepatitis B virus envelope protein is not necessary for infectivity of hepatitis delta virus publication-title: J Virol doi: 10.1128/jvi.68.6.4063-4066.1994 contributor: fullname: C Sureau – volume: 12 start-page: 3503 issue: 3 year: 2015 ident: ppat.1009983.ref015 article-title: Hepatitis B virus upregulates the expression of kinesin family member 4A publication-title: Mol Med Rep doi: 10.3892/mmr.2015.3792 contributor: fullname: CL Zhu – volume: 63 start-page: 1945 issue: 5 year: 1989 ident: ppat.1009983.ref057 article-title: Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen publication-title: J Virol doi: 10.1128/jvi.63.5.1945-1950.1989 contributor: fullname: MY Kuo – volume: 9 start-page: 3225 issue: 18 year: 2018 ident: ppat.1009983.ref048 article-title: Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. publication-title: J Cancer doi: 10.7150/jca.26052 contributor: fullname: L Yang – volume: 67 start-page: 542 issue: 3 year: 2018 ident: ppat.1009983.ref019 article-title: Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo publication-title: Gut doi: 10.1136/gutjnl-2016-312162 contributor: fullname: L Allweiss – volume: 12 start-page: 712241 year: 2021 ident: ppat.1009983.ref029 article-title: The MS Remyelinating Drug Bexarotene (an RXR Agonist) Promotes Induction of Human Tregs and Suppresses Th17 Differentiation In Vitro. publication-title: Front Immunol doi: 10.3389/fimmu.2021.712241 contributor: fullname: CM Gaunt – volume: 61 start-page: 260 issue: 1 year: 2015 ident: ppat.1009983.ref034 article-title: Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype. publication-title: Hepatology doi: 10.1002/hep.27240 contributor: fullname: FM Vaz – volume: 81 start-page: 4343 issue: 8 year: 2007 ident: ppat.1009983.ref059 article-title: Two potentially important elements of the hepatitis B virus large envelope protein are dispensable for the infectivity of hepatitis delta virus publication-title: J Virol doi: 10.1128/JVI.02478-06 contributor: fullname: S Gudima – volume: 10 start-page: 74 year: 2020 ident: ppat.1009983.ref030 article-title: E-cadherin Plays a Role in Hepatitis B Virus Entry Through Affecting Glycosylated Sodium-Taurocholate Cotransporting Polypeptide Distribution. publication-title: Front Cell Infect Microbiol doi: 10.3389/fcimb.2020.00074 contributor: fullname: Q Hu – volume: 290 start-page: 5673 issue: 9 year: 2015 ident: ppat.1009983.ref041 article-title: Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression. publication-title: J Biol Chem doi: 10.1074/jbc.M114.602540 contributor: fullname: S Tsukuda – volume: 166 start-page: 991 issue: 7 year: 2004 ident: ppat.1009983.ref008 article-title: Loss of KLP-19 polar ejection force causes misorientation and missegregation of holocentric chromosomes publication-title: J Cell Biol doi: 10.1083/jcb.200403036 contributor: fullname: J Powers – volume: 280 start-page: G1305 issue: 6 year: 2001 ident: ppat.1009983.ref033 article-title: Cell-specific basolateral membrane sorting of the human liver Na(+)-dependent bile acid cotransporter. publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.2001.280.6.G1305 contributor: fullname: AQ Sun – volume: 55 start-page: 373 issue: 2 year: 2012 ident: ppat.1009983.ref032 article-title: Hepatocyte polarization is essential for the productive entry of the hepatitis B virus publication-title: Hepatology doi: 10.1002/hep.24707 contributor: fullname: A Schulze |
SSID | ssj0041316 |
Score | 2.4637344 |
Snippet | Intracellular transport via microtubule-based dynein and kinesin family motors plays a key role in viral reproduction and transmission. We show here that... |
SourceID | plos doaj pubmedcentral proquest gale crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e1009983 |
SubjectTerms | Adenosine triphosphatase Agonists Biology and life sciences Care and treatment Cell division Cell surface Depletion Development and progression Dynein Family Filaments Fractionation Gene expression Genes Genetic aspects Genomes Health aspects Hep G2 Cells Hepatitis B Hepatitis B virus - physiology Hepatitis Delta Virus - physiology Humans Immunofluorescence Immunoprecipitation Infections Intracellular Kinesin Kinesins - genetics Life cycles Liver cancer Localization Medicine and Health Sciences Methods Molecular targeted therapy Organic Anion Transporters, Sodium-Dependent - genetics Organic Anion Transporters, Sodium-Dependent - metabolism Patient outcomes Proteins Receptors Research and Analysis Methods Retinoid X receptors Retinoid X Receptors - agonists siRNA Symporters - genetics Symporters - metabolism Transfection Virus Internalization Viruses |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9tAEF5aQ6GX0nfcpGVbCj2plncl7e4xL-NQMMVJQ25iX0pMi2QsK5B_0J_dmZUsqpLSS08C71hiZ0Y736CZbwj5yDwEYebjKLFcY4IiI5loFzGjvDQmFsqGIbbnYnElT06RJqcf9YU1YS09cKu4iZ9mBWdOFDZJwb-U0qnJphCmM5tOM-PD6RvLXTLVnsFwMoehpzgUJxI8y7qmOS6mk85Gn9drjfTRgJAkHwSlwN3fn9Cj9Y-qvg9-_llF-VtYmj0lTzo8SQ_bfTwjD3z5nDxqJ0zevSA_wQ3odyxtX5X0y9ksoaFVBPAlnR9dTuYnlzSMFqHdvB64erpp59ODxWhV0LrZFNp6urg4_kpD6OtaN6kuHQXLUONpW1DuHTV3dHm1pPq6QkremsJjb1fbTfWSfJudXhzPo274QmQhZG8jJo0CfRmAXwCBUkheMyc590go6QtMO5TXqYgdc7FNvBDCARYyxVTJxGrAMa_IqKxKv0co4kinmLQasETinMQ0kxu4iVVammRMop3283XLsZGHD20CcpNWjTlaK--sNSZHaKJeFhmyww_gN3nnN_m__GZMPqCBc-TAKLHI5lo3dZ2fnS_yw0wpwGlxwv8qtBwIfeqEigocwequsQE2j9xaA8mDgSS8yXawvIfOtttznbMsRcDOEwb_3Dng_cvv-2W8KRbOlb5qUAbZiTLBQOZ166-93jicv4BexZiIgScPFDtcKVc3gYJcKoFEQW_-hyX2yWOGPSWhsO-AjLabxr8lD2vXvAsv9S_l8Uv7 priority: 102 providerName: Directory of Open Access Journals |
Title | The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35312737 https://www.proquest.com/docview/2651150342 https://search.proquest.com/docview/2641856722 https://pubmed.ncbi.nlm.nih.gov/PMC8970526 https://doaj.org/article/e16f32d7fc4542599a5b616006c516be http://dx.doi.org/10.1371/journal.ppat.1009983 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF5qQ6GX0nfcpmFbCj3Jj9Vjd4-JE-NQaoKThtzEvuSaJpKw7EL-QX92Z1aSqUp66cngHcnWzOzON_bMN4R8Yg6CMHPjIDKhwgRFBCJSNmBaOqH1mEvjh9he8sWNOD1Dmpy47YXxRftGr4f57d0wX3_3tZXlnRm1dWKji69TITnSlIx6pAfYsE3R6-MXDmU_7xTn4QQ8TJKmXy7kk1FjnmFZKmSOBnAkcI5OCH4IUZx3QpNn8N-f0_3ytqgeAqF_11L-EZxmz8jTBlXS4_rbPyePXP6CPK7nTN6_JL_AGegPLHBf5_TL-SyivmEEUCadn1yP5qfX1A8Yoc3UHnh1dFNPqQe70SKj1W6TKePo4mp6QX0AbBo4qcotBftQ7WhdVu4s1fd0ebOkalUgMW9F4WN_rreb4hX5Nju7ms6DZgRDYCBwbwMmtATVaQBhAIRiSGETK8LQIa2kyzD5kE7FfGyZHZvIcc4tICKdTaSIjAI085r08yJ3B4QimrSSCaMAUUTWCkw2Qw03MVIJHQ1I0Go_LWumjdT_3cYhQ6nVmKLh0sZwA3KCJtrLIk-2f6PYrNLGW1I3SbKQWZ6ZKIbTSUoV62QCIC8x8STRbkA-ooFTZMLIsdRmpXZVlZ5fLtLjREpAa-Mo_KfQsiP0uRHKCnAEo5r2Bnh4ZNjqSB52JGE_m87yATpb-8xVypIYYXsYMbiydcCHlz_sl_GmWD6Xu2KHMshRlHAGMm9qf93rrfX-AeEdT-4otrsC-9ITkTf78O1_X_mOPGHYTuJr-g5Jf7vZufekV9ndkf9x5Mhv7d_i8E4b |
link.rule.ids | 230,315,729,782,786,866,887,2108,27935,27936,53803,53805 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF7RIAQX3tBAgQUhcXLi-LW7xzZtlKhtVKWl6s3al0NEa0dxgtR_wM9mZm1HGJVLT5GyY0e7MzvzjTLzDSFfAwtBOLC-F-lQYoLCPR5J4wVKWK6Uz4R2Q2zP2fSKHx4hTU7c9MK4on2tFr38-qaXL3642srlje43dWL9s9MhFwxpSvo75CHcVz9skvTKAYNbdhNPcSKOx8IkqTvmQjbo1wrqLZcSuaMBHnGcpBOCJUIcZ63g5Dj8t566s7wuyrtg6L_VlH-Fp9Gze27sOXla41G6Xy2_IA9s_pI8qiZU3r4iv8GM6E8sjV_k9HgyiqhrNQF8SscHl_3x4SV1o0loPe8HPi1dVfPtQeO0yGi5WWVSWzq9GJ5RFzrr1k8qc0NBs1RZWhWkW0PVLZ1dzaicF0jpW1L42V-L9ap4Tb6Pji6GY68e3uBpCPlrL-BKwJErgG8AoWJIfhPDw9AiIaXNMG0RVsbMN4HxdWQZYwawlMoGgkdaAg56Qzp5kdtdQhGHGhFwLQGLRMZwTFNDBS_RQnIVdYnXaC1dVhwdqfujjkFuUx1jigpPa4V3yQGqdiuLDNvui2I1T2t1pHaQZGFgWKajGPyaEDJWyQDgYaLjQaJsl3xBw0iRQyPHIp253JRlOjmfpvuJEIDz_Cj8r9CsJfStFsoKMCAt68YI2Dxyc7Uk91qS4Al0a3kXjbTZc5kGSYyAP4wCeLIx3LuXP2-X8aVYeJfbYoMyyG6UsABk3lZ2vj235tZ0CWvdgNbBtlfA8B2FeW3o7-795CfyeHxxepKeTKbH78mTAJtSXGXgHumsVxv7geyUZvPROYY_6DVitg |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF7RIBAX3tBAgQUhcXLs-LXrY5s0alSIorRUvVn7cohobStOkPoP-NnMrO0Io3KBU6Ts2NHuzM58o8x8Q8hH30AQ9o3nhCoQmKBwh4dCO75MDJfSY4myQ2zP2OySj4-RJmc36ssW7Su5GuRX14N89c3WVpbXym3rxNz5lxFPGNKUuKXO3D1yF-6sF7WJeu2EwTXbqac4FcdhQRw3XXMBG7qNkgZlKZA_GiASx2k6AVgjxHLWCVCWx3_nrXvlVVHdBkX_rKj8LURNHv3H5h6Thw0upYe1yBNyx-RPyb16UuXNM_ITzIl-xxL5VU5Pp5OQ2pYTwKn05OjCPRlfUDuihDZzf-DT0HU95x40T4uMVtt1JpShs_PRnNoQ2rSAUpFrChqm0tC6MN1oKm_o4nJBxbJAat-Kws_-WG3WxXPydXJ8PjpxmiEOjoLQv3F8LhM4dgkwDqBUBElwrHkQGCSmNBmmL4kREfO0rz0VGsaYBkwls2HCQyUAD70gvbzIzT6hiEd14nMlAJOEWnNMVwMJL1GJ4DLsE6fVXFrWXB2p_cOOQY5TH2OKSk8bpffJEap3J4tM2_aLYr1MG5WkZhhnga9ZpsII_FuSiEjGQ4CJsYqGsTR98gGNI0UujRyLdZZiW1Xp9GyWHsZJAnjPC4O_Ci06Qp8aoawAI1KiaZCAzSNHV0fyoCMJHkF1lvfRUNs9V6kfRwj8g9CHJ1vjvX35_W4ZX4oFeLkptiiDLEcx80HmZW3ru3Nrb06fsM4t6BxsdwWM31KZN8b-6p-ffEfuz8eT9PN0dvqaPPCxN8UWCB6Q3ma9NW_IXqW3b61v-AUKpGU2 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+kinesin+KIF4+mediates+HBV%2FHDV+entry+through+the+regulation+of+surface+NTCP+localization+and+can+be+targeted+by+RXR+agonists+in+vitro&rft.jtitle=PLoS+pathogens&rft.au=Gad%2C+Sameh+A&rft.au=Sugiyama%2C+Masaya&rft.au=Tsuge%2C+Masataka&rft.au=Wakae%2C+Kosho&rft.date=2022-03-01&rft.eissn=1553-7374&rft.volume=18&rft.issue=3&rft.spage=e1009983&rft.epage=e1009983&rft_id=info:doi/10.1371%2Fjournal.ppat.1009983&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1553-7374&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1553-7374&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1553-7374&client=summon |